Staff Spotlight: Bryan Gullick, PhD, Research Scientist Bryan, tell us about PCR in the development and conduct of pharmacology and toxicology studies PCR assay development closely follows the in vivo studies required to support an IND. Along this path from pharmacology to toxicology the scientific team reviews, and evaluates what species to utilize. They will consider […]
Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route Follow these critical steps on your path to IND application. By Philip J. Kuehl, PhD, Senior Scientist and Director of Scientific Core Laboratories, Lovelace Biomedical and Jacob D. McDonald , PhD, Senior Scientist and Chief Scientific Officer, Lovelace Biomedical Cell and gene therapy […]
was the year of the scientist. In a culture where we primarily celebrate the accomplishments of artists or the affluent, this year we celebrated the accomplishments, knowledge and capabilities of scientists and, in a sense, science. It is always fun to be working on research that is topical to the well-being of humankind. This […]
As translational researchers we’re faced with many challenges in determining the best routes and methods for delivering inhaled therapeutics that will allow for precise targeted dosing and maximum benefit to the patient, especially now with the ongoing COVID-19 pandemic. Thus, we aimed to delineate some of this complexity by comparing the pulmonary distribution of a […]
2019’s ACT meeting in Phoenix, AZ was the 40th Annual Meeting and brought some key highlights to the Lovelace Biomedical team. In addition to catching up with colleagues, scientists and business development team members had the opportunity to attend continuing education courses and scientific sessions in toxicology. In reviewing highlights with the scientific staff, several […]
Thinking about Scientific and professional development. As I reflect upon 2019 and the different trade shows I attended over 2019, it was an interesting year, with one show standing out for something other than scientific content. As the pharmaceutical industry has shifted over the last 10 years with travel budgets severely restricted since 2008, most […]
Highlighting our excellent staff at Lovelace Biomedical Today’s staff spotlight belongs to Janet Benson. Janet is one of Lovelace’s longest tenured scientist, with decades of experience and also one of the most respected and well-known leaders in the gene therapy space. Here, Janet gives us a little glimpse into her career, inspiration, and interests. […]
It was reinvigorating to get out from behind the desk, and out of the lab this past weekend to attend the 2019 NACFC in Nashville. First, a couple of admissions – I was only able to attend the last day and a half of the meeting, and this was my first time attending this one […]
Traumatic Brain Injury (TBI) is just one of the many areas of scientific study Lovelace Biomedical, along with its sister company the Mind Research Network (MRN), has in its repertoire. Dr. Andy Mayer, Professor of Translational Neuroscience at MRN is studying mild TBI, with the goal of improving diagnosis and treatment of cognitive deficits following […]
Highlighting our excellent staff at Lovelace Biomedical Today, we put the spotlight on Adam Werts. Adam recently joined Lovelace Biomedical as part of our veterinary research team. Adam gives us an insight to his life, his career, and what he’s up to since joining Lovelace Biomedical. Bio: I spent the first twenty-two years of my […]
